SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Bradley CJ, Yabroff KR, Dahman B, Feuer EJ, Mariotto A, Brown ML. Productivity costs of cancer mortality in the United States: 2000-2020. J Natl Cancer Inst. 2008;100:1763-1770.
  • 2
    Ekwueme DU, Chesson HW, Zhang KB, Balamurugan A. Years of potential life lost and productivity costs because of cancer mortality and for specific cancer sites where human papillomavirus may be a risk factor for carcinogenesis-United States, 2003. Cancer. 2008;113:2936-2945.
  • 3
    Hoerger TJ, Ekwueme DU, Miller JW, et al. Estimated effects of the National Breast and Cervical Cancer Early Detection Program on breast cancer mortality. Am J Prev Med. 2011;40:397-404.
  • 4
    Howard DH, Ekwueme DU, Gardner JG, Tangka FK, Li C, Miller JW. The impact of a national program to provide free mammograms to low-income, uninsured women on breast cancer mortality rates. Cancer. 2010;116:4456-4462.
  • 5
    Steiner JF, Cavender TA, Nowels CT, et al. The impact of physical and psychosocial factors on work characteristics after cancer. Psychooncology. 2008;17:138-147.
  • 6
    Subramanian S, Trogdon J, Ekwueme DU, Gardner JG, Whitmire JT, Rao C. Cost of cervical cancer treatment: implications for providing coverage to low-income women under the Medicaid expansion for cancer care. Womens Health Issues. 2010;20:400-405.
  • 7
    Subramanian S, Trogdon J, Ekwueme DU, Gardner JG, Whitmire JT, Rao C. Cost of breast cancer treatment in Medicaid: implications for state programs providing coverage for low-income women. Med Care. 2011;49:89-95.
  • 8
    Yabroff KR, Bradley CJ, Mariotto AB, Brown ML, Feuer EJ. Estimates and projections of value of life lost from cancer deaths in the United States. J Natl Cancer Inst. 2008;100:1755-1762.
  • 9
    Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367:1998-2005.
  • 10
    Woloshin S, Schwartz LM. The benefits and harms of mammography screening: understanding the trade-offs. JAMA. 2010;303:164-165.
  • 11
    Croswell JM, Ransohoff DF, Kramer BS. Principles of cancer screening: lessons from history and study design issues. Semin Oncol. 2010;37:202-215.
  • 12
    Lee NC, Wong FL, Jamison PM, et al. Implementation of the National Breast and Cervical Cancer Early Detection Program: The beginning. Cancer. 2014;120(16 Suppl.):2540-2548.
  • 13
    Henson RM, Wyatt SW, Lee NC. The National Breast and Cervical Cancer Early Detection Program: a comprehensive public health response to two major health issues for women. J Public Health Manag Pract. 1996;2:36-47.
  • 14
    Screening for Breast Cancer, Topic Page. July 2010. U.S. Preventive Services Task Force. Available at: http://www.uspreventiveservicestaskforce.org/uspstf/uspsbrca.htm. Accessed September 6, 2013.
  • 15
    Screening for Cervical Cancer, Topic Page. April 2012. U.S. Preventive Services Task Force. Available at: http://www.uspreventiveservicestaskforce.org/uspstf/uspscerv.htm. Accessed September 6, 2013.
  • 16
    Richardson LC, Royalty J, Howe W, Helsel W, Kammerer W, Benard VB. Timeliness of breast cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection Program, 1996-2005. Am J Public Health. 2010;100:1769-1776.
  • 17
    Benard VB, Howe W, Royalty J, Helsel W, Kammerer W, Richardson LC. Timeliness of cervical cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection Program. J Womens Health (Larchmt). 2012;21:776-782.
  • 18
    DeGroff A, Royalty J, Howe W, et al. When performance management works: a study of the National Breast and Cervical Cancer Early Detection Program. Cancer. 2014;120(16 Suppl.):2566-2574.
  • 19
    Yancy B, DeGroff A, Royalty J, Marroulis S, Mattingly C, Benard VB. Using Data to Effectively Manage a National Screening Program. Cancer. 2014;120(16 Suppl.):2575-2583.
  • 20
    Nelson HD, Tyne K, Naik A, et al. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;151:727-737, W237-742.
  • 21
    Jemal A, Simard EP, Dorell C, et al. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst. 2013;105:175-201.
  • 22
    National Cancer Institute. Cancer Trends Progress Report-2011/2012 Update. National Institutes of Health, Dept of Health and Human Services, Bethesda, MD, 2010.
  • 23
    U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999-2010 Incidence and Mortality Web-based Report. Available at: http://apps.nccd.cdc.gov/uscs/index.aspx. Accessed June 4, 2014.
  • 24
    Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333.
  • 25
    Clarke CA, Glaser SL, Uratsu CS, Selby JV, Kushi LH, Herrinton LJ. Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence. J Clin Oncol. 2006;24:e49-e50.
  • 26
    Elmore JG, Fletcher SW. The risk of cancer risk prediction: "What is my risk of getting breast cancer"? J Natl Cancer Inst. 2006;98:1673-1675.
  • 27
    Otto SJ, Fracheboud J, Verbeek AL, et al. Mammography screening and risk of breast cancer death: a population-based case-control study. Cancer Epidemiol Biomarkers Prev. 2012;21:66-73.
  • 28
    Berry DA, Inoue L, Shen Y, et al. Modeling the impact of treatment and screening on U.S. breast cancer mortality: a Bayesian approach. J Natl Cancer Inst Monogr. 2006:30-36.
  • 29
    Berry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353:1784-1792.
  • 30
    Centers for Disease C, Prevention. Vital signs: racial disparities in breast cancer severity--United States, 2005-2009. MMWR Morb Mortal Wkly Rep. 2012;61:922-926.
  • 31
    National Cancer Institute. Fast Stats: An interactive tool for access to SEER cancer statistics. Surveillance Research Program. Available at: http://seer.cancer.gov/faststats. Accessed August 15, 2013.
  • 32
    Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
  • 33
    Moyer VA for USPSTF. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;156:880-891.
  • 34
    Fontaine PL, Saslow D, King VJ. ACS/ASCCP/ASCP guidelines for the early detection of cervical cancer. Am Fam Physician. 2012;86:501, 506-507.
  • 35
    Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin. 2012;62:147-172.
  • 36
    Pierce Campbell CM, Menezes LJ, Paskett ED, Giuliano AR. Prevention of invasive cervical cancer in the United States: past, present, and future. Cancer Epidemiol Biomarkers Prev. 2012;21:1402-1408.
  • 37
    Eheman C, Henley SJ, Ballard-Barbash R, et al. Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer. 2012;118:2338-2366.
  • 38
    Fruchter RG, Boyce J, Hunt M. Missed opportunities for early diagnosis of cancer of the cervix. Am J Public Health. 1980;70:418-420.
  • 39
    National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Breast Cancer Screening and Diagnosis. Version 1. Available at: http://www.nccn.org/professionals/physician_gls/pdf/breast-screening.pdf 2013. Accessed March 25, 2013.
  • 40
    Massad LS, Einstein MH, Huh WK, et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. 2013;17:S1-S27.
  • 41
    Siegel EJ, Miller JW, Kahn K, Harris SE, Roland KB. Quality Assurance through Quality Improvement and Professional Development in the National Breast and Cervical Cancer Early Detection Program. Cancer. 2014;120(16 Suppl.):2584-2590.
  • 42
    Lobb R, Allen JD, Emmons KM, Ayanian JZ. Timely care after an abnormal mammogram among low-income women in a public breast cancer screening program. Arch Intern Med. 2010;170:521-528.
  • 43
    Lantz PM, Richardson LC, Sever LE, et al. Mass screening in low-income populations: the challenges of securing diagnostic and treatment services in a national cancer screening program. J Health Polit Policy Law. 2000;25:451-471.
  • 44
    Tangka FK, Dalaker J, Chattopadhyay SK, et al. Meeting the mammography screening needs of underserved women: the performance of the National Breast and Cervical Cancer Early Detection Program in 2002-2003 (United States). Cancer Causes Control. 2006;17:1145-1154.
  • 45
    Tangka FK, O'Hara B, Gardner JG, et al. Meeting the cervical cancer screening needs of underserved women: the National Breast and Cervical Cancer Early Detection Program, 2004-2006. Cancer Causes Control. 2010;21:1081-1090.
  • 46
    Centers for Disease Control and Prevention, Division of Cancer Prevention and Control. National Breast and Cervical Cancer Early Detection Program, About the Program. Available at: http://www.cdc.gov/cancer/nbccedp/about.htm, Accessed February 15, 2013.
  • 47
    Miller JW, King JB, Joseph DA, Richardson LC, Centers for Disease C, Prevention. Breast cancer screening among adult women—Behavioral Risk Factor Surveillance System, United States, 2010. MMWR Morb Mortal Wkly Rep. 2012;61(Suppl):46-50.
  • 48
    Centers for Disease C, Prevention. Cancer screening - United States, 2010. MMWR Morb Mortal Wkly Rep. 2012;61:41-45.
  • 49
    U.S. Department of Health and Human Services. Healthy People 2020. Available at: http://www.healthypeople.gov/2020/default.aspx. Accessed March 12, 2013.